Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
21.2M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$277M
-
Value change
-
+$28.3M
-
Number of buys
-
25
-
Number of sells
-
-9
-
Price
-
$13.01
Significant Holders of Benitec Biopharma Inc. - Common Stock (BNTC) as of Q1 2025
40 filings reported holding BNTC - Benitec Biopharma Inc. - Common Stock as of Q1 2025.
Benitec Biopharma Inc. - Common Stock (BNTC) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.2M shares
of 33.9M outstanding shares and own 62.73% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (9.88M shares), JANUS HENDERSON GROUP PLC (2.92M shares), FRANKLIN RESOURCES INC (2.86M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.97M shares), Nantahala Capital Management, LLC (838K shares), INFINITUM ASSET MANAGEMENT, LLC (475K shares), VANGUARD GROUP INC (327K shares), Schonfeld Strategic Advisors LLC (262K shares), SILVERARC CAPITAL MANAGEMENT, LLC (250K shares), and GEODE CAPITAL MANAGEMENT, LLC (234K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.